AzTrials
AzTrials

Intimate Partner ViolenceNCT03397277

Promoting Safety Behaviours in Antenatal Care Using a Video

A study testing Safety behaviour promoting video in people with Intimate Partner Violence, run by Oslo Metropolitan University at 19 sites in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigates the effect of a video which teaches 15 safety behaviours for women subject to intimate partner violence (IPV) during pregnancy. Half of the women screening positive for IPV during pregnancy will view the intervention video. The other half will view a control video. Read more about this study

Who is it for?
Ages 18 to 60 years, women only
Conditions the study is for
Intimate Partner Violence
What is being tested?
Safety behaviour promoting video
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
250 participants
Where
19 sitesNorway
Study dates
15 Jan 2018to 15 Sep 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • pregnant women attending antenatal care at the community health center,
  • 18 years or older,
  • understanding sufficient Norwegian, Urdu, Somali or English to complete the questionnaire and understand the video.

Who cannot join

  • women who do not speak or understand the languages provided in the study (English, Urdu, Somali and Norwegian)
  • women who have never been in an adult intimate relationship
  • women who are closely attended by male partner
  • women who do not have the mental of physical capacity to answer the questionnaire.
  • women who cannot fill out the questionnaire in privacy

Trial locations and contacts

19 sites in 1 country.

19 sites in 1 country

Norway19 sites
  • Nordberg

    Ås

  • Ås Community Health Center

    Ås

  • Trøgstad Community Health Center

    Askim

  • Rælingen Community Health Center

    Flateby

  • Familie Hus Halden

    Halden

  • Aurskog- Høland Community Health Center

    Høland

  • Jevnaker Community Health Center

    Jevnaker

  • Lillestrøm Communicy Health Center

    Lillestrøm

  • Nesodden Community Health Center

    Nesoddtangen

  • Oppegård Community Health Center

    Oppegård

  • Grorud Community Health Center

    Oslo, 0905

  • Bjerke Community Center

    Oslo

  • Health Centre Alna

    Oslo

  • Stovner Community Health Center

    Oslo

  • Rakkestad Community Health Center

    Rakkestad

  • Skedsmo Community Health Center

    Skedsmokorset

  • Langhus

    Ski

  • Ski Community Health Center

    Ski

  • Våler Community Health Center

    Våler

Other trials in Norway

About this study

Official title: Preparing for the Worst - Promoting Safety Behaviours in Antenatal Care Among Norwegian, Pakistani and Somali Pregnant Women

This study investigates the effect of a video which teaches 15 safety behaviours for women subject to intimate partner violence (IPV) during pregnancy. Half of the women screening positive for IPV during pregnancy will view the intervention video. The other half will view a control video.

Read the detailed description

Intimate partner violence (IPV) poses a risk for the health of the woman during pregnancy also for the health of the unborn child. Pregnancy is time when nearly all women have regular contact with the healthcare system. Pregnancy is also a time during which women consider their situation and are open for change.

Healthcare staff have the opportunity to ask pregnant women if they experience IPV and need to know how to respond to women experiencing IPV. Healthcare staff can refer to other services. If staff are uncertain if referral is needed or wanted they can teach women how to increase their own safety and prepare for leaving through a number of safety promoting behaviours.The safety behaviours were originally developed in the USA to counsel women who attended a family violence unit and qualified for a protection order.

Women do not always disclose the true nature of their IPV to staff. However, they could still benefit from learning about safety promoting behaviours. Using a video for teaching allows for the use of pictures and sound and options for several languages.

Being tested
Safety behaviour promoting video, Control video
Keywords
IPV

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Safety behaviour promoting videoBehavioural

    A 7 min. video which teaches 15 different safety behaviours to reduce violence or the effect of violence

  • Control videoBehavioural

    A 7 min. video which teaches women about safety regarding food, alcohol, smoking, medication and physical activity during pregnancy

Study groups in NCT03397277
Study groupRoleWhat they receive
Screened positive intervention videoExperimentalSafety behaviour promoting video
Receives: Behavioral: Safety behaviour promoting video
Screened positive control videoSham comparatorPregnant women who screen positive for IPV using the AAS who are randomized into viewing the control video
Receives: Behavioral: Control video

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adoption of safety behaviours

    Number of used safety behaviours

    Measured: change from pregnancy to 3 months postpartum

  2. The World Health Organisation Quality of Life Brief (WHOQOL-BREF)

    A scale of 26 items assessing four dimensions of quality of life (QOL), physical, psychological, environmental and social. Low score equals low QOL. Mean scores are calculated for each domain.

    Measured: Change from pregnancy to 3 months postpartum

Secondary outcomes (2)
  1. Prevalence of Intimate Partner Violence (IPV) measured using Composite Abuse Scale (revised) - Short Form (CAS R SF)

    CAS(R)-SF is a 15-item instrument capturing physical, sexual and psychological abuse and overall IPV. Total score ranges from 0 to 75. Low score indicates less violence. Mean total score is calculated and compared.

    Measured: change from pregnancy to 3 months postpartum

  2. Symptoms of depression

    Edinburgh Depression Scale -5 (short version)

    Measured: Change from pregnancy to 3 months postpartum. Minimum score is 0, maximum score is 15. The lower the score the fewer symptoms of depression the person has. A cut-off of 7 or more is used to indicate symptoms of depression.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2018
  2. Study start15 Jan 2018
  3. Primary completion30 Jun 2020
  4. Study completion15 Sep 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Pregnant women will be screened for IPV using a modified version of the Abuse Assessment Screening. Women who screen positive are randomized into either the intervention video or a control video. Women screening negative for violence will be shown the control video. All women receive standard care and a card with high quality websites about safe pregnancy. Hidden among these is a webside that informs women about IPV (rights, safety etc..). Three months after birth all the women screening positive for violence will receive another questionnaire to fill out. In addition will a random sample of women who screened negative for IPV be asked to fill out a questionnaire at the same time. This group will be double the size of the women screening positive.
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03397277
Sponsor's protocol ID
260355
Status last verified
Sep 2020
First submitted
24 Oct 2017
Last updated
21 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Flaathen EME, Henriksen L, Smastuen MC, Schei B, Taft A, Noll J, Garnweidner-Holme L, Lukasse M. Safe Pregnancy intervention for intimate partner violence: a randomised controlled trial in Norway among culturally diverse pregnant women. BMC Pregnancy Childbirth. 2022 Feb 21;22(1):144. doi: 10.1186/s12884-022-04400-z.

    PubMed 35189843
  • Walter B, Indreboe H, Lukasse M, Henriksen L, Garnweidner-Holme L. Pregnant Women's Attitudes Toward and Experiences With a Tablet Intervention to Promote Safety Behaviors in a Randomized Controlled Trial: Qualitative Study. JMIR Form Res. 2021 Jul 20;5(7):e28680. doi: 10.2196/28680.

    PubMed 34283023
  • Garnweidner-Holme L, Henriksen L, Flaathen EM, Klette Bohler T, Lukasse M. Midwives' Attitudes Toward and Experience With a Tablet Intervention to Promote Safety Behaviors for Pregnant Women Reporting Intimate Partner Violence: Qualitative Study. JMIR Mhealth Uhealth. 2020 May 20;8(5):e16828. doi: 10.2196/16828.

    PubMed 32432553
  • Henriksen L, Flaathen EM, Angelshaug J, Garnweidner-Holme L, Smastuen MC, Noll J, Taft A, Schei B, Lukasse M. The Safe Pregnancy study - promoting safety behaviours in antenatal care among Norwegian, Pakistani and Somali pregnant women: a study protocol for a randomized controlled trial. BMC Public Health. 2019 Jun 10;19(1):724. doi: 10.1186/s12889-019-6922-y.

    PubMed 31182062

Questions about this trial

What is this clinical trial studying?

A study testing Safety behaviour promoting video in people with Intimate Partner Violence, run by Oslo Metropolitan University at 19 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 19 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adoption of safety behaviours (time frame: change from pregnancy to 3 months postpartum). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03397277, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in